Navigation Links
FDA Panel Backs At-Home HIV Test
Date:5/16/2012

By Randy Dotinga
HealthDay Reporter

TUESDAY, May 15 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel recommended Tuesday approval of the first HIV test that would give people the results in the privacy of their own home.

The 17 panel members were unanimous in voting that the benefits of the test were greater than any possible risks. The test kit, known as Oraquick, detects the presence of HIV -- the virus that causes AIDS -- within 20 minutes, the Associated Press reported.

If the FDA heeds the recommendation of its advisory panel, the decision could pave the way toward a new era in HIV testing. The agency typically follows the recommendations of its advisory groups.

OraSure Technologies Inc., which makes the over-the-counter test, already sells a version of it to doctors and other health professionals. Studies have shown the test was less accurate when used by consumers, but the panelists said Tuesday that the benefits of expanding HIV testing outweigh a small drop in test accuracy, according to the AP.

"There is huge global momentum in support of over-the-counter testing for HIV. People desire private, discreet options that protect their confidentiality," said Dr. Nitika Pant Pai, an assistant professor of medicine at Montreal's McGill University who co-authored an analysis of the effectiveness of an at-home HIV test earlier this year.

The test, which looks for signs of HIV in oral fluid, is already used at hospitals and doctors' offices where medical professionals administer it. The FDA first approved its use in 2004.

To take the OraQuick test, people swab their outer gums and put the swab into a vial. After about 20 minutes, the test device will reveal two reddish-purple lines in a small window if there are signs that the body's immune system has geared up to battle HIV.

The test uses oral fluid, which is not the same as saliva. Its results
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Panel to Consider At-Home HIV Test
2. FDA Panel Gives Blessing to New Weight-Loss Drug
3. U.S. Panel Rejects Ovarian Cancer Screening
4. Panel of serum biomarkers may reduce number of lung biopsies needed
5. FDA Panel Cites Clot Risk From Contraceptive Patch
6. Panel endorses active monitoring and delay of treatment for low-risk prostate cancer
7. Expert Panel Pinpoints Environmental Culprits in Breast Cancer
8. FDA Panels to Weigh Safety of Newer Forms of the Pill
9. Panel of melanoma mutations opens door to new treatment possibilities
10. Many on Medical Guideline Panels Have Conflicts of Interest: Study
11. Panels Rejection of PSA Test Spurs Mixed Reaction From Experts
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Backs At-Home HIV Test
(Date:5/5/2015)... After record-breaking sales of Extend ... introduces the Cookies & Cream flavor at stores nationwide ... has continually raised the bar for nutritional snacks. ... an unprecedented nutritional profile, backed by international patents and ... will launch additional new products and expand retail availability ...
(Date:5/5/2015)... 2015 Dealing with injuries and medical expenses ... task. Personal injury lawyers are excellent resources for accident victims ... In their latest article , the Jones Firm gives the ... choosing a personal injury lawyer to handle their case. , ... a waste of time if the lawyer does not have ...
(Date:5/5/2015)... The report “Liver Fibrosis ... analysis on the therapeutic development for Liver ... identifying new targets and MOAs to produce ... available at http://www.rnrmarketresearch.com/liver-fibrosis-pipeline-review-h2-2014-market-report.html . , ... Pipeline Review, H2 2014 report include ACROVIS ...
(Date:5/5/2015)... 2015 Texting has become a common and ... some physicians text as a way to communicate with patients ... are doing so to assure medical records are updated after ... risk! When providers transmit protected health information (PHI), or ... the risk of violating the Health Insurance Portability and Accountability ...
(Date:5/5/2015)... 05, 2015 No one cares about health ... Disease Control and Prevention cite multiple sources causing poor ... “Poor indoor air quality (pollution) can bother your eyes, nose, ... lung problems and cancer.” , Toxic chemicals often get into ... food or water, or in some cases, absorb them through ...
Breaking Medicine News(10 mins):Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:5 Top Qualifications for Personal Injury Lawyer Disclosed in Latest Article by The Jones Firm 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 2Health News:Liver Fibrosis Therapeutic Development and Pipeline Market Review H2 2014 Available at RnRMarketResearch.com 3Health News:HIPAA Compliant Texting Service from MedXcom now available for Policyholders 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 2Health News:revitaRUGS is Offering Area Rug Cleaning Discounts in Support of Asthma and Allergy Awareness Month This May 3
... Pharmacologic Agent Developed for the Treatment of Premature ... ... Janssen-Cilag companies in,Europe have submitted a Marketing Authorisation Application (MAA) for,dapoxetine, ... Premature ejaculation is a form of male sexual dysfunction associated,with ...
... time, review shows , , FRIDAY, Dec. 7 (HealthDay News) -- The ... of death, from suicide as well as other causes, a new ... days following the loss. , More research needs to be done ... according to the article in the Dec. 8 issue of ...
... PRINCETON, N.J., Dec. 7 Medarex, Inc.,(Nasdaq: ... an undisclosed,milestone payment from its licensing partner, Centocor, ... of ustekinumab,(CNTO 1275) in the United States and ... severe plaque psoriasis by Centocor., Ustekinumab is ...
... CNN Worldwide and its global audience,paid special tribute tonight ... as "CNN Heroes" in a global telecast.,CNN,s Anderson Cooper ... the American Museum of Natural History in New York,City., ... initiative has shone a,spotlight upon dozens of amazing people ...
... Mass., Dec. 6 Inverness Medical,Innovations, Inc. (Amex: ... of rapid,diagnostic products for the consumer and professional ... 2007 RBC Capital Markets Healthcare,Conference being held December ... City. Ron Zwanziger, Chief Executive Officer, and Jon ...
... Dec. 6 A gene related to rapid replication ... to contain some identical,protein sequences in, tobacco mosaic virus ... for cancer, the AMAS(R) test, appears,to measure this gene,s ... of reports on the use of a new,methodology to ...
Cached Medicine News:Health News:Submission of Marketing Authorisation Application for Dapoxetine in Europe 2Health News:Mourning Death of Loved One Raises Your Risk of Dying 2Health News:Mourning Death of Loved One Raises Your Risk of Dying 3Health News:Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis 2Health News:Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis 3Health News:CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event 2Health News:CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event 3Health News:CNN Honors Extraordinary Deeds of Seven Everyday People in Global Event 4Health News:Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 2Health News:AMAS Test Measures Lethal Replikin Gene Activity in Lung and Other Cancers 3
(Date:5/4/2015)... 4, 2015  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... has joined the company as Vice President, Medical Affairs. ... Dr. Bill Aurora to the Neurocrine team ... Gorman , President and Chief Executive Officer of Neurocrine ... and outreach coupled with his extensive network and influence ...
(Date:5/4/2015)... Microbrush International, a leading developer, producer and ... procedures, today announced the acquisition of DentiSmart LLC. ... matrix system used in dental restorative procedures. ... to add DentiSmart to our growing portfolio of ... and General Manager of Microbrush. "DentiSmart,s products are ...
(Date:5/4/2015)... , May 4, 2015  The board of directors of ... a dividend for the second quarter of 2015 of $0.50 ... dividend is payable June 10, 2015, to shareholders of record ... About Eli Lilly and Company Lilly is a global healthcare ... for people around the world. We were founded more than ...
Breaking Medicine Technology:Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 2Neurocrine Biosciences, Inc. Announces Appointment of Dr. Bill Aurora as Vice President, Medical Affairs 3Microbrush International Announces Acquisition of DentiSmart 2
... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the Stifel Nicolaus Healthcare ... 2:40 p.m. Eastern Time.  Dr. Sands will provide an ...
... Aug. 30, 2011 Reportlinker.com announces that a ... its catalogue: Specialty Pharmaceutical ... http://www.reportlinker.com/p0512130/Specialty-Pharmaceutical-Industry---2011-Yearbook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology Summary ... Industry - 2011 Yearbook" essentially provides insights ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference 2Specialty Pharmaceutical Industry - 2011 Yearbook 2Specialty Pharmaceutical Industry - 2011 Yearbook 3Specialty Pharmaceutical Industry - 2011 Yearbook 4Specialty Pharmaceutical Industry - 2011 Yearbook 5Specialty Pharmaceutical Industry - 2011 Yearbook 6Specialty Pharmaceutical Industry - 2011 Yearbook 7Specialty Pharmaceutical Industry - 2011 Yearbook 8Specialty Pharmaceutical Industry - 2011 Yearbook 9Specialty Pharmaceutical Industry - 2011 Yearbook 10Specialty Pharmaceutical Industry - 2011 Yearbook 11Specialty Pharmaceutical Industry - 2011 Yearbook 12Specialty Pharmaceutical Industry - 2011 Yearbook 13Specialty Pharmaceutical Industry - 2011 Yearbook 14Specialty Pharmaceutical Industry - 2011 Yearbook 15Specialty Pharmaceutical Industry - 2011 Yearbook 16
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 10.0 mm and length 12 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
Medicine Products: